Skip to main content
. 2017 Jul 1;216(Suppl 1):S1–S8. doi: 10.1093/infdis/jix117

Figure 2.

Figure 2.

Rationale, risks, mitigation strategies, and operational considerations for withdrawal of the type 2 component of oral poliovirus vaccine (OPV2). Abbreviations: AFP, acute flaccid paralysis; bOPV, bivalent oral poliovirus vaccine; cVDPV, type 2 circulating vaccine-derived poliovirus; IPV, inactivated poliovirus vaccine; mOPV, monovalent oral poliovirus vaccine; tOPV, trivalent oral poliovirus vaccine; WPV2, type 2 wild poliovirus.